Articles with public access mandates - Sara SheikhbahaeiLearn more
Not available anywhere: 3
18F-FDG PET/CT and melanoma: value of fourth and subsequent posttherapy follow-up scans for patient management
E Mena, M Taghipour, S Sheikhbahaei, S Mirpour, J Xiao, ...
Clinical nuclear medicine 41 (9), e403-e409, 2016
Mandates: US National Institutes of Health
Molecular imaging and precision medicine: PET/computed tomography and therapy response assessment in oncology
S Sheikhbahaei, E Mena, P Pattanayak, M Taghipour, LB Solnes, ...
PET clinics 12 (1), 105-118, 2017
Mandates: US National Institutes of Health
Diagnostic performance of IQ· SPECT with high-speed scanning: A preliminary quality control study in obese patients
RA Werner, RB Martinez, C Marcus, MJ Kruse, S Sheikhbahaei, ...
Journal of Nuclear Cardiology 29 (6), 3443-3449, 2022
Mandates: German Research Foundation
Available somewhere: 33
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic …
T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ...
The lancet 386 (9995), 743-800, 2015
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of …
M Correction Naghavi, H Wang, R Lozano, A Davis, X Liang, M Zhou, ...
The Lancet 385 (9963), 117-171, 2015
Mandates: Swiss National Science Foundation, Hewlett Foundation, Bill & Melinda Gates …
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic …
GBD 2015 Risk Factors Collaborators
Lancet (London, England) 388 (10053), 1659, 2016
Mandates: US National Science Foundation, Bill & Melinda Gates Foundation, US National …
The global burden of cancer 2013
C Fitzmaurice, D Dicker, A Pain, H Hamavid, M Moradi-Lakeh, ...
JAMA oncology 1 (4), 505-527, 2015
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, US …
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the …
NJ Kassebaum, M Arora, RM Barber, ZA Bhutta, J Brown, A Carter, ...
The Lancet 388 (10053), 1603-1658, 2016
Mandates: Swiss National Science Foundation, Bill & Melinda Gates Foundation, US …
Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …
JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ...
JAMA oncology 8 (3), 420-444, 2022
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the …
A Pourshams, SG Sepanlou, KS Ikuta, C Bisignano, S Safiri, G Roshandel, ...
The lancet Gastroenterology & hepatology 4 (12), 934-947, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, Fundação …
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the …
RM Barber, N Fullman, RJD Sorensen, T Bollyky, M McKee, E Nolte, ...
The lancet 390 (10091), 231-266, 2017
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ...
The Lancet 400 (10352), 563-591, 2022
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
AP Patel, JL Fisher, E Nichols, F Abd-Allah, J Abdela, A Abdelalim, ...
The Lancet Neurology 18 (4), 376-393, 2019
Mandates: Bill & Melinda Gates Foundation, Department of Science & Technology, India …
Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ...
The Lancet 400 (10347), 185-235, 2022
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ...
European journal of nuclear medicine and molecular imaging 44, 2117-2136, 2017
Mandates: US National Institutes of Health
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ...
The Lancet Oncology 23 (1), 27-52, 2022
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, American …
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
H Ebrahimi, Z Aryan, SS Moghaddam, C Bisignano, S Rezaei, F Pishgar, ...
The Lancet Respiratory Medicine 9 (9), 1030-1049, 2021
Mandates: Bill & Melinda Gates Foundation, National Institute for Health Research, UK …
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the …
F Kamangar, D Nasrollahzadeh, S Safiri, SG Sepanlou, C Fitzmaurice, ...
The lancet Gastroenterology & hepatology 5 (6), 582-597, 2020
Mandates: Bill & Melinda Gates Foundation, US Department of Veterans Affairs, Fundação …
Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls
S Sheikhbahaei, RA Werner, LB Solnes, KJ Pienta, MG Pomper, ...
Seminars in nuclear medicine 49 (4), 255-270, 2019
Mandates: US National Institutes of Health, European Commission
A systematic review and meta-analysis of the effectiveness and toxicities of lutetium-177–labeled prostate-specific membrane antigen–targeted radioligand therapy in metastatic …
MS Sadaghiani, S Sheikhbahaei, RA Werner, KJ Pienta, MG Pomper, ...
European urology 80 (1), 82-94, 2021
Mandates: US National Institutes of Health, European Commission
Publication and funding information is determined automatically by a computer program